Cyclooxygenase inhibitors for treating preterm labour: What is the molecular evidence? (Record no. 19707)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02062nam a22002897a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305193737.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 221125b |||||||| |||| 00| 0 eng d |
| 028 ## - PUBLISHER OR DISTRIBUTOR NUMBER | |
| Source | Phone: +255 28 298 3384 |
| Source | Fax: +255 28 298 3386 |
| Source | Email: vc@bugando.ac.tz |
| Source | Website: www.bugando.ac.tz |
| 040 ## - CATALOGING SOURCE | |
| Language of cataloging | English |
| Transcribing agency | DLC |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Daniela Urrego |
| 9 (RLIN) | 45996 |
| 245 ## - TITLE STATEMENT | |
| Title | Cyclooxygenase inhibitors for treating preterm labour: What is the molecular evidence? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mwanza, Tanzania: |
| Name of publisher, distributor, etc. | NRC Research Press & |
| -- | Catholic University of Health and Allied Sciences [CUHAS – Bugando] |
| Date of publication, distribution, etc. | 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | Pages 222-231 |
| 490 ## - SERIES STATEMENT | |
| Volume/sequential designation | Canadian Journal of Physiology and Pharmacology Volume 97 Issue 3 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Preterm birth (<37 weeks of gestation) significantly increases the risk of neonatal mortality and morbidity. As many as half of all preterm births occur following spontaneous preterm labour. Since in such cases there are no known reasons for the initiation of labour, treatment of preterm labour (tocolysis) has sought to stop labour contractions and delay delivery. Despite some success, the use of cyclooxygenase (COX) inhibitors is associated with maternal/fetal side effects, and possibly increased risk of preterm birth. Clinical use of these drugs predates the collection of molecular and biochemical evidence in vitro, examining the expression and activity of COX enzymes in pregnant uterine tissues with and without labour. Such evidence is important to the rationale that COX enzymes are, or are not, appropriate targets for the tocolysis. The current study systematically searched existing scientific evidence to address the … |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 23052 |
| 9 (RLIN) | 45997 |
| 9 (RLIN) | 45998 |
| 9 (RLIN) | 45999 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2C33oewAAAAJ&citation_for_view=2C33oewAAAAJ:roLk4NBRz8UC">https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2C33oewAAAAJ&citation_for_view=2C33oewAAAAJ:roLk4NBRz8UC</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | RESEARCH ARTICLES |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/25/2022 | RA0915 | 11/25/2022 | RA0915 | 11/25/2022 | RESEARCH ARTICLES |